메뉴 건너뛰기




Volumn 12, Issue 1, 2013, Pages

Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: A comparative analysis from two placebo-controlled relapse prevention studies

Author keywords

Long acting injectable; Paliperidone extended release; Paliperidone palmitate; Post hoc analysis

Indexed keywords

PALIPERIDONE; PLACEBO;

EID: 84880007260     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-12-22     Document Type: Article
Times cited : (32)

References (17)
  • 1
    • 0036307453 scopus 로고    scopus 로고
    • Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics
    • 10.2165/00023210-200216070-00004, 12056922
    • Csernansky JG, Schuchart EK. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics. CNS Drugs 2002, 16:473-484. 10.2165/00023210-200216070-00004, 12056922.
    • (2002) CNS Drugs , vol.16 , pp. 473-484
    • Csernansky, J.G.1    Schuchart, E.K.2
  • 2
    • 0842263782 scopus 로고    scopus 로고
    • A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
    • 10.1016/S0924-977X(03)00109-3, 15013023
    • Bhanji NH, Chouinard G, Margolese H. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropsychopharmacol 2004, 14:87-92. 10.1016/S0924-977X(03)00109-3, 15013023.
    • (2004) Eur Neuropsychopharmacol , vol.14 , pp. 87-92
    • Bhanji, N.H.1    Chouinard, G.2    Margolese, H.3
  • 3
    • 74549129561 scopus 로고    scopus 로고
    • Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review
    • 10.4088/PCC.08r00612, 2736032, 19750066
    • Masand PS, Roca M, Turner MS, Kane JM. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 2009, 11:147-154. 10.4088/PCC.08r00612, 2736032, 19750066.
    • (2009) Prim Care Companion J Clin Psychiatry , vol.11 , pp. 147-154
    • Masand, P.S.1    Roca, M.2    Turner, M.S.3    Kane, J.M.4
  • 4
    • 79958233416 scopus 로고    scopus 로고
    • A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia
    • 10.1176/appi.ajp.2011.10081224, 21362741
    • Tiihonen J, Haukka J, Taylor M, Haddad PM, Patel MX, Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 2011, 168:603-609. 10.1176/appi.ajp.2011.10081224, 21362741.
    • (2011) Am J Psychiatry , vol.168 , pp. 603-609
    • Tiihonen, J.1    Haukka, J.2    Taylor, M.3    Haddad, P.M.4    Patel, M.X.5    Korhonen, P.6
  • 5
    • 0036773689 scopus 로고    scopus 로고
    • Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature
    • 10.4088/JCP.v63n1007, 12416599
    • Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002, 63:892-909. 10.4088/JCP.v63n1007, 12416599.
    • (2002) J Clin Psychiatry , vol.63 , pp. 892-909
    • Lacro, J.P.1    Dunn, L.B.2    Dolder, C.R.3    Leckband, S.G.4    Jeste, D.V.5
  • 6
    • 72849116914 scopus 로고    scopus 로고
    • A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome
    • 10.4088/JCP.09m05284yel, 19906343
    • Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. J Clin Psychiatry 2009, 70:1397-1406. 10.4088/JCP.09m05284yel, 19906343.
    • (2009) J Clin Psychiatry , vol.70 , pp. 1397-1406
    • Weiden, P.J.1    Schooler, N.R.2    Weedon, J.C.3    Elmouchtari, A.4    Sunakawa, A.5    Goldfinger, S.M.6
  • 7
    • 4544230571 scopus 로고    scopus 로고
    • Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics
    • 10.4088/JCP.v65n0809, 15323593
    • Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. J Clin Psychiatry 2004, 65:1084-1089. 10.4088/JCP.v65n0809, 15323593.
    • (2004) J Clin Psychiatry , vol.65 , pp. 1084-1089
    • Lindenmayer, J.P.1    Eerdekens, E.2    Berry, S.A.3    Eerdekens, M.4
  • 8
    • 76149108173 scopus 로고    scopus 로고
    • Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety
    • 10.1002/hup.1085, 20041474
    • Hawley C, Turner M, Latif MA, Curtis V, Saleem PT, Wilton K. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety. Hum Psychopharmacol 2010, 25:37-46. 10.1002/hup.1085, 20041474.
    • (2010) Hum Psychopharmacol , vol.25 , pp. 37-46
    • Hawley, C.1    Turner, M.2    Latif, M.A.3    Curtis, V.4    Saleem, P.T.5    Wilton, K.6
  • 9
    • 72849146000 scopus 로고    scopus 로고
    • Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia
    • 10.1002/hup.1057, 19790174
    • Kim SW, Shin IS, Kim JM, Lee SH, Lee YH, Yang SJ, Yoon JS. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia. Hum Psychopharmacol 2009, 24:565-573. 10.1002/hup.1057, 19790174.
    • (2009) Hum Psychopharmacol , vol.24 , pp. 565-573
    • Kim, S.W.1    Shin, I.S.2    Kim, J.M.3    Lee, S.H.4    Lee, Y.H.5    Yang, S.J.6    Yoon, J.S.7
  • 10
    • 77950915234 scopus 로고    scopus 로고
    • Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome
    • 10.1002/hup.1108, 20373476
    • Lloyd K, Latif MA, Simpson S, Shrestha KL. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome. Hum Psychopharmacol 2010, 25:243-252. 10.1002/hup.1108, 20373476.
    • (2010) Hum Psychopharmacol , vol.25 , pp. 243-252
    • Lloyd, K.1    Latif, M.A.2    Simpson, S.3    Shrestha, K.L.4
  • 12
    • 33746874424 scopus 로고    scopus 로고
    • A comparative efficacy and safety study of long-acting risperidone injection and risperidone oral tablets among hospitalized patients: 12-week randomized, single-blind study
    • 10.1055/s-2006-946703, 16900609
    • Bai YM, Chen TT, Wu B, Hung CH, Lin WK, Hu TM, Lin CY, Chou P. A comparative efficacy and safety study of long-acting risperidone injection and risperidone oral tablets among hospitalized patients: 12-week randomized, single-blind study. Pharmacopsychiatry 2006, 39:135-141. 10.1055/s-2006-946703, 16900609.
    • (2006) Pharmacopsychiatry , vol.39 , pp. 135-141
    • Bai, Y.M.1    Chen, T.T.2    Wu, B.3    Hung, C.H.4    Lin, W.K.5    Hu, T.M.6    Lin, C.Y.7    Chou, P.8
  • 13
    • 33846235456 scopus 로고    scopus 로고
    • Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study
    • 10.1097/JCP.0b013e31802dda4a, 17224706
    • Kramer M, Simpson G, Maciulis V, Kushner S, Vijapurkar U, Lim P, Eerdekens M. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2007, 27:6-14. 10.1097/JCP.0b013e31802dda4a, 17224706.
    • (2007) J Clin Psychopharmacol , vol.27 , pp. 6-14
    • Kramer, M.1    Simpson, G.2    Maciulis, V.3    Kushner, S.4    Vijapurkar, U.5    Lim, P.6    Eerdekens, M.7
  • 14
    • 74449091850 scopus 로고    scopus 로고
    • Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study
    • 10.1016/j.schres.2009.10.026, 19959339
    • Hough D, Gopal S, Vijapurkar U, Lim P, Morozova M, Eerdekens M. Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res 2010, 116:107-117. 10.1016/j.schres.2009.10.026, 19959339.
    • (2010) Schizophr Res , vol.116 , pp. 107-117
    • Hough, D.1    Gopal, S.2    Vijapurkar, U.3    Lim, P.4    Morozova, M.5    Eerdekens, M.6
  • 15
    • 67650495255 scopus 로고    scopus 로고
    • Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER
    • 10.1185/03007990903010623, 19469696
    • Knapp M, Locklear J, Jarbrink K. Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER. Curr Med Res Opin 2009, 25:1593-1603. 10.1185/03007990903010623, 19469696.
    • (2009) Curr Med Res Opin , vol.25 , pp. 1593-1603
    • Knapp, M.1    Locklear, J.2    Jarbrink, K.3
  • 16
    • 69849099693 scopus 로고    scopus 로고
    • Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia: a novel once-monthly, long-acting formulation of an atypical antipsychotic
    • 10.2165/11316870-000000000-00000, 19725593
    • Samtani MN, Vermeulen A, Stuyckens K. Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia: a novel once-monthly, long-acting formulation of an atypical antipsychotic. Clin Pharmacokinet 2009, 48:585-600. 10.2165/11316870-000000000-00000, 19725593.
    • (2009) Clin Pharmacokinet , vol.48 , pp. 585-600
    • Samtani, M.N.1    Vermeulen, A.2    Stuyckens, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.